The Defender

The Defender

Share this post

The Defender
The Defender
Bavarian Nordic Tests Mpox Vaccine in 2- to 11-Year-Olds, Critics Question Safety and Need

Bavarian Nordic Tests Mpox Vaccine in 2- to…

The Defender
Nov 2, 2024
10

Share this post

The Defender
The Defender
Bavarian Nordic Tests Mpox Vaccine in 2- to 11-Year-Olds, Critics Question Safety and Need
1
6

Bavarian Nordic on Tuesday announced the launch of clinical trials for its MVA-BN mpox vaccine for children ages 2 to 11. Participants will receive two doses of the vaccine.

Read →
1 Comment
User's avatar
GeoffPainPhD's avatar
GeoffPainPhD
Nov 2

More on Jynneos

https://geoffpain.substack.com/p/monkey-pox-jabbing-harms

Expand full comment
Reply
Share
© 2025 The Defender
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share